Questions
about Psychotropic Medications for Children
Q: Are there situations in which it is advisable to use
psychotropic medications in young children?
A: Psychotropic medications may be prescribed for young children with
mental, behavioral, or emotional symptoms when the potential benefits of
treatment outweigh the risks. Some problems are so severe and persistent
that they would have serious negative consequences for the child if
untreated, and psychosocial interventions may not always be effective by
themselves. The safety and efficacy of most psychotropic medications have
not yet been studied in young children. As a parent, you will want to ask
many questions and evaluate with your doctor the risks of starting and
continuing your child on these medications. Learn everything you can about
the medications prescribed for your child, including potential side
effects. Learn which side effects are tolerable and which ones are
threatening. In addition, learn and keep in mind the goals of a particular
treatment (e.g., change in specific behaviors). Combining multiple
psychotropic medications should be avoided in very young children unless
absolutely necessary.
Q: Does medication affect young children differently from older
children or adults?
A: Yes. Young children's bodies handle medications differently than
older individuals and this has implications for dosage. The brains of
young children are in a state of very rapid development, and animal
studies have shown that the developing neurotransmitter systems can be
very sensitive to medications. A great deal of research is still needed to
determine the effects and benefits of medications in children of all ages.
Yet it is important to remember that serious untreated mental disorders
themselves negatively impact brain development.
Q: If my preschool child receives a diagnosis of a mental
disorder, does this mean that medications have to be used?
A: No. Psychotropic medications are not generally the first option for
a preschool child with a mental disorder. The first goal is to understand
the factors that may be contributing to the condition. The child's own
physical and emotional state is key, but many other factors such as
parental stress or a changing family environment may influence the child's
symptoms. Certain psychosocial treatments may be as effective as
medication.
Q: How should medication be included in an overall treatment
plan?
A: When medication is used, it should not be the only strategy. There
are other services that you may want to investigate for your child. Family
support services, educational classes, behavior management techniques, as
well as family therapy and other approaches should be considered. If
medication is prescribed, it should be monitored and evaluated regularly.
Q: What difference does it make if a medication is specifically
approved for use in children or not?
A: Approval of a medication by the U.S. Food and Drug Administration
(FDA) means that adequate data have been provided to the FDA by the drug
manufacturer to show safety and efficacy for a particular therapy in a
particular population. Based on the data, a label indication for the drug
is established that includes proper dosage, potential side effects, and
approved age. Doctors prescribe medications as they feel appropriate even
if those uses are not included in the labeling. Although in some cases
there is extensive clinical experience in using medications for children
or adolescents, in many cases there is not. Everyone agrees that more
studies in children are needed if we are to know the appropriate dosages,
how a drug works in children, and what effects there are on learning and
development.
Q: What does "off-label" use of a medication mean?
A: Many medications that are on the market have not been officially
approved by the FDA for use in children. Treatment of children with these
medications is called "off-label" use. For some medications, the
off-label use is supported by data from well-conducted studies in
children. For instance, some antidepressant medications have been shown to
be effective in children and adolescents with depression. For other
medications, there are no controlled studies in children, but only
isolated clinical reports. In particular, the use of psychotropic
medications in preschoolers has not been adequately studied and must be
considered very carefully by balancing severity of symptoms, degree of
impairment, and potential benefits and risks of treatment.
Q: Why haven't many medications been tested in children?
A: In the past, medications were not studied in children because of
ethical concerns about involving children in clinical trials. However,
this created a new problem: lack of knowledge about the best treatments
for children. In clinical settings where children are suffering from
mental or behavioral disorders, medications are being prescribed at
increasingly early ages. The FDA has been urging that products be
appropriately studied in children and has offered incentives to drug
manufacturers to carry out such testing. The NIH and the FDA are examining
the issue of medication research in children and are developing new
research approaches.
Q: Does the FDA approve medications for different age groups
among children?
A: Yes. However, this is based on the data provided to the FDA by the
drug manufacturer and the policies in effect at the time of approval. For
example, Ritalin® is approved for children age 6 and older, whereas
Dexedrine® is approved for children as young as 3. When Ritalin® was
tested for efficacy by its manufacturer, only children age 6 and above
were involved; therefore, age 6 was approved as the lower age limit for
Ritalin®.
Information
provided by the National Institute of Mental Health
Types
of Medication
Medications
for Children
Children and Mental Health
|